Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

NCT01624805 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia
de Novo Myelodysplastic Syndrome
Myelodysplastic Syndrome
Previously Treated Myelodysplastic Syndrome

Interventions

BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Cyclosporine
BIOLOGICAL: Filgrastim
DRUG: Methylprednisolone
BIOLOGICAL: Pegfilgrastim

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]